COMPANY PROFILE // THE 014 REPORT
Nexentis Technologies Inc.
NXTS (Nasdaq) · Formerly: N2OFF, Inc.; Save Foods, Inc.; Save Foods Inc.
Assembled from 2 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-09-03 and 2 more times (last 24 months).
- Amber8-K Item 4.01 filed: change in the company's certifying accountant (auditor) on 2026-08-06 (last 24 months).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Nexentis Technologies Inc. is an SEC-registered operating company in pharmaceutical preparations, incorporated in NV, based in New York, NY; listed as NXTS (Nasdaq).[source] It reported revenue of $210,000 for the fiscal year ended 2024-12-31.[source] It has filed 56 documents with the SEC in the last 12 months; the latest is Form 4, filed 2026-11-16.[source] Seraphix flags 2 items from these records: 8-K Item 4.01 filed; 8-K Item 3.01 filed.[source]
- red0
- amber2
- info0
- CLEAR26
- POSSIBLE MATCH0
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Barda Lital · Chief Financial Officer (Officer) · latest Form 4 2026-02-11 · filing · LinkedIn search
- Palach David · Chief Executive Officer (Officer) · latest Form 4 2026-02-11 · filing · LinkedIn search
- Zakai Shlomo · Controller (Officer) · latest Form 4 2026-02-11 · filing · LinkedIn search
- Weiss Amitay · Director · latest Form 4 2026-02-11 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- Greenberg Traurig, P.A. · Exhibit 5.1 legal opinion, S-1 filed 2026-07-13
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001789192 | source |
| EIN | 26-4684680 | source |
| Business address (SEC) | 156 FIFTH AVENUE 10TH FLOOR, NEW YORK, NY, 10010-7751 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- DUKE Robotics Corp. · Zakai Shlomo
- SciSparc Ltd. · Weiss Amitay
- Maris Tech Ltd. · Weiss Amitay
- Nexera Technologies Ltd · Weiss Amitay
- ParaZero Technologies Ltd. · Weiss Amitay
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-16 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-10 filing 8-K items 3.02 · SEC EDGAR
- 2026-11-09 filing PRE 14A · SEC EDGAR
- 2026-11-06 filing 8-K items 3.03,5.03,8.01,9.01 · SEC EDGAR
- 2026-10-19 filing PRE 14A · SEC EDGAR
- 2026-10-19 officer change 8-K items 3.02,5.02 · SEC EDGAR
- 2026-10-06 filing 8-K items 1.01,9.01 · SEC EDGAR
- 2026-10-05 filing PRE 14A · SEC EDGAR
- 2026-09-03 filing 8-K items 3.01 · SEC EDGAR
- 2026-08-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-06 filing 8-K items 4.01,9.01 · SEC EDGAR
- 2026-07-17 filing EFFECT · SEC EDGAR
- 2026-07-15 filing EFFECT · SEC EDGAR
- 2026-07-13 filing Registration (S-1) · SEC EDGAR
- 2026-07-13 filing POS AM · SEC EDGAR
- 2026-06-23 filing 424B5 · SEC EDGAR
- 2026-06-22 filing 8-K items 1.01,3.02,9.01 · SEC EDGAR
- 2026-06-15 filing 424B5 · SEC EDGAR
- 2026-06-12 filing 8-K items 1.01,3.02,9.01 · SEC EDGAR
- 2026-05-27 filing 8-K items 1.01,2.03,9.01 · SEC EDGAR
- 2026-05-14 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-04-30 filing 8-K items 5.07 · SEC EDGAR
- 2026-04-29 filing EFFECT · SEC EDGAR
- 2026-04-28 filing CORRESP · SEC EDGAR
- 2026-04-27 filing UPLOAD · SEC EDGAR
- 2026-04-16 filing S-3 · SEC EDGAR
- 2026-04-06 filing 8-K items 3.03,5.03,9.01 · SEC EDGAR
- 2026-03-31 filing Annual report (10-K) · SEC EDGAR
- 2026-03-17 filing 8-K items 2.01,9.01 · SEC EDGAR
- 2026-03-12 filing Proxy statement · SEC EDGAR
170 earlier entries
- 2026-03-02 filing PRE 14A
- 2026-02-26 filing 8-K items 3.02
- 2026-02-25 filing 8-K items 5.03,7.01
- 2026-02-25 name change Name changed from N2OFF, Inc.
- 2026-02-11 insider First Form 3/4/5 on record for Zakai Shlomo (Controller)
- 2026-02-11 insider First Form 3/4/5 on record for Weiss Amitay (Director)
- 2026-01-13 filing 8-K items 1.01,3.02,9.01
- 2026-01-12 filing 8-K items 3.02
- 2025-12-16 filing 8-K items 3.02,5.07
- 2025-11-13 filing Quarterly report (10-Q)
- 2025-11-12 filing 8-K/A items 8.01,9.01
- 2025-11-03 filing Proxy statement
- 2025-10-24 filing PRE 14A
- 2025-10-23 filing 8-K items 2.01,3.02,8.01,9.01
- 2025-10-08 filing 8-K items 3.01,8.01,9.01
- 2025-09-25 filing 8-K items 5.07,8.01,9.01
- 2025-09-18 filing 8-K items 8.01,9.01
- 2025-09-09 filing 8-K items 1.01,3.03,5.03,9.01
- 2025-08-27 filing 424B3
- 2025-08-22 filing EFFECT
- 2025-08-20 filing CORRESP
- 2025-08-19 filing S-1/A
- 2025-08-19 filing UPLOAD
- 2025-08-18 filing 8-K items 1.01,9.01
- 2025-08-14 filing Quarterly report (10-Q)
- 2025-08-14 filing 8-K items 1.01,2.03,3.02,9.01
- 2025-08-06 filing Registration (S-1)
- 2025-08-05 filing Proxy statement
- 2025-07-30 filing UPLOAD
- 2025-07-28 filing 8-K items 1.01,3.02,9.01
- 2025-07-25 filing PREM14A
- 2025-07-24 filing 8-K items 1.01,9.01
- 2025-05-22 filing 8-K items 1.01,9.01
- 2025-05-15 filing Quarterly report (10-Q)
- 2025-05-13 filing 8-K items 1.01,2.03,3.02,9.01
- 2025-05-12 officer change 8-K items 3.02,5.02
- 2025-05-12 insider First Form 3/4/5 on record for Barda Lital (Chief Financial Officer)
- 2025-05-12 insider First Form 3/4/5 on record for Palach David (Chief Executive Officer)
- 2025-04-10 filing 8-K items 1.01,9.01
- 2025-03-31 filing Annual report (10-K)
- 2025-03-31 filing 8-K items 3.01
- 2025-03-20 filing 8-K items 1.01,9.01
- 2025-03-19 filing UPLOAD
- 2025-03-17 filing 8-K items 1.01,9.01
- 2025-03-12 filing CORRESP
- 2025-03-06 filing UPLOAD
- 2025-02-28 filing 8-K items 1.01
- 2025-02-27 filing PRE 14A
- 2025-02-26 filing 8-K items 1.01,7.01,9.01
- 2025-02-18 filing 424B3
- 2025-02-14 filing EFFECT
- 2025-02-14 filing CORRESP
- 2025-02-14 filing S-1/A
- 2025-02-07 filing S-1/A
- 2025-02-07 filing 8-K items 8.01
- 2025-01-24 filing UPLOAD
- 2025-01-17 filing Registration (S-1)
- 2025-01-15 filing 8-K items 7.01,9.01
- 2025-01-08 filing 8-K items 8.01
- 2025-01-06 filing 8-K items 3.02
- 2024-12-26 filing 8-K items 1.01,3.02,9.01
- 2024-12-12 filing 8-K items 1.01,9.01
- 2024-12-10 filing 8-K items 1.01,2.01,3.02
- 2024-11-18 filing 8-K items 1.01,9.01
- 2024-11-14 filing Quarterly report (10-Q)
- 2024-11-13 filing 8-K items 5.07
- 2024-11-12 filing DEFA14A
- 2024-11-12 filing 8-K items 5.03,9.01
- 2024-10-02 filing 8-K items 1.01,2.03,3.02,7.01,9.01
- 2024-09-25 officer change 8-K items 3.02,5.02
- 2024-09-19 filing Proxy statement
- 2024-09-12 filing 8-K items 7.01,9.01
- 2024-09-09 filing PRE 14A
- 2024-08-27 filing 8-K items 7.01,9.01
- 2024-08-14 filing Quarterly report (10-Q)
- 2024-07-31 filing 8-K items 1.01,2.03,7.01,9.01
- 2024-07-09 filing 8-K items 3.01
- 2024-07-03 filing 8-K items 5.07
- 2024-05-31 filing Proxy statement
- 2024-05-20 filing PRE 14A
- 2024-05-15 filing Quarterly report (10-Q)
- 2024-04-16 filing 8-K items 1.01,2.03,3.02,9.01
- 2024-04-01 filing Annual report (10-K)
- 2024-03-19 filing 8-K items 5.03,7.01,9.01
- 2024-03-19 name change Name changed from Save Foods, Inc.
- 2024-02-21 filing 8-K items 7.01,9.01
- 2024-02-12 filing 8-K items 8.01,9.01
- 2024-02-09 filing 8-K items 5.07,8.01,9.01
- 2024-02-07 filing 424B3
- 2024-02-06 filing EFFECT
- 2024-02-05 filing CORRESP
- 2024-02-02 filing S-1/A
- 2024-01-19 filing UPLOAD
- 2024-01-11 filing Registration (S-1)
- 2024-01-09 filing Proxy statement
- 2023-12-29 filing PRE 14A
- 2023-12-26 officer change 8-K items 1.01,3.02,5.02,9.01
- 2023-12-18 officer change 8-K items 5.02
- 2023-11-14 filing Quarterly report (10-Q)
- 2023-11-13 officer change 8-K items 5.02
- 2023-11-09 filing 8-K items 1.01,3.03,5.03,9.01
- 2023-11-02 filing 8-K items 1.01,2.03,9.01
- 2023-10-31 filing 424B3
- 2023-10-30 filing EFFECT
- 2023-10-26 filing CORRESP
- 2023-10-26 filing S-1/A
- 2023-10-23 filing 8-K items 8.01
- 2023-10-20 filing UPLOAD
- 2023-10-12 filing DEL AM
- 2023-10-11 filing Registration (S-1)
- 2023-10-05 filing 8-K items 3.03,5.03,9.01
- 2023-10-02 filing 8-K items 5.07
- 2023-09-25 filing 8-K items 8.01,9.01
- 2023-08-16 filing 8-K items 1.01,9.01
- 2023-08-15 filing Proxy statement
- 2023-08-14 filing Quarterly report (10-Q)
- 2023-07-31 filing PRE 14A
- 2023-07-28 filing 8-K items 1.01,3.02,9.01
- 2023-07-27 filing 8-K items 1.01,3.02,9.01
- 2023-07-18 officer change 8-K items 5.02
- 2023-07-12 filing 8-K items 1.01,9.01
- 2023-06-22 filing 8-K/A items 9.01
- 2023-05-15 filing Quarterly report (10-Q)
- 2023-04-27 filing 8-K items 3.01
- 2023-04-11 filing 8-K items 8.01,9.01
- 2023-04-10 name change Name changed from Save Foods Inc.
- 2023-04-06 officer change 8-K items 1.01,3.02,5.02,8.01,9.01
- 2023-04-05 officer change 8-K items 5.02
- 2023-03-27 filing Annual report (10-K)
- 2023-01-23 officer change 8-K items 5.02
- 2022-11-14 filing Quarterly report (10-Q)
- 2022-08-30 officer change 8-K items 5.02,5.07,9.01
- 2022-08-24 filing 8-K items 5.03,9.01
- 2022-08-24 filing DEFR14A
- 2022-08-18 filing 8-K items 1.01,8.01,9.01
- 2022-08-17 filing 424B5
- 2022-08-15 filing 424B5
- 2022-08-15 filing Quarterly report (10-Q)
- 2022-07-22 filing EFFECT
- 2022-07-20 filing CORRESP
- 2022-07-18 filing UPLOAD
- 2022-07-18 filing Proxy statement
- 2022-07-15 filing S-3
- 2022-07-05 filing PRE 14A
- 2022-06-30 filing 8-K items 7.01,9.01
- 2022-05-16 filing Quarterly report (10-Q)
- 2022-04-18 officer change 8-K items 5.02
- 2022-03-31 filing Annual report (10-K)
- 2022-03-10 filing 8-K items 7.01,9.01
- 2022-02-24 filing 8-K items 7.01,9.01
- 2022-01-19 officer change 8-K items 5.02
- 2021-11-15 filing Quarterly report (10-Q)
- 2021-11-09 filing 8-K items 8.01,9.01
- 2021-08-18 filing 8-K items 7.01,9.01
- 2021-08-16 filing Quarterly report (10-Q)
- 2021-07-26 filing 8-K items 4.01,9.01
- 2021-06-09 filing 8-K items 7.01,9.01
- 2021-05-19 officer change 8-K items 5.02,9.01
- 2021-05-18 filing Quarterly report (10-Q)
- 2021-05-18 filing 8-K items 1.01,8.01,9.01
- 2021-05-17 filing 424B4
- 2021-05-17 filing NT 10-Q
- 2021-05-13 filing EFFECT
- 2021-05-13 filing CERT
- 2021-05-11 filing 8-A12B
- 2021-05-11 filing CORRESP
- 2021-05-11 filing CORRESP
- 2021-04-06 filing S-1/A
- 2021-03-29 filing Annual report (10-K)
- 2021-03-16 filing Registration (S-1)
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-16 (within 7 days) 10-Q filed
- 2026-11-10 (within 30 days) 8-K filed: Item 3.02 unregistered equity sale
- 2026-11-09 (within 30 days) PRE 14A filed
- 2026-11-06 (within 30 days) 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 8.01 other event; Item 9.01 exhibits
- 2026-10-19 (older) PRE 14A filed
- 2026-10-19 (older) 8-K filed: Item 3.02 unregistered equity sale; Item 5.02 officer or director change
- 2026-10-06 (older) 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2026-10-05 (older) PRE 14A filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-19; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:NXTS The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1789192 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | NXTS / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 264684680 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001789192 | SEC EDGAR / IRS |
| CUSIP | 80512Q501 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001789192 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2024-12-31) | $210,000 | 2024-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-19 15:58 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$4,004,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-19 15:58 UTC | Report an error |
| Total assets (at 2025-12-31) | $20,405,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-19 15:58 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $16,010,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-19 15:58 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $3,832,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-19 15:58 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 15:58 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 15:58 UTC | Report an error |
| State of incorporation | NV | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 15:58 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 15:58 UTC | Report an error |
| Business address | 156 FIFTH AVENUE 10TH FLOOR, CO EARTHBOUND LLC, NEW YORK, NY, 10010-7751 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 15:58 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 15:58 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$3,808,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-19 15:58 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $14,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-19 15:58 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $15,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-19 15:58 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001493152-26-052070
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Net income (loss) | $5,029,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-16 | 0001493152-26-052070 | 2026-11-19 15:58 UTC | Report an error |
| Cash and cash equivalents | $2,837,000 | at 2026-09-30 | 10-Q | 2026-11-16 | 0001493152-26-052070 | 2026-11-19 15:58 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-16 Filing 10-Q filed
- 2026-11-10 Filing 8-K filed: Item 3.02 unregistered equity sale
- 2026-11-09 Filing PRE 14A filed
- 2026-11-06 Filing 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 8.01 other event; Item 9.01 exhibits
- 2026-10-19 Filing PRE 14A filed
- 2026-10-19 Filing 8-K filed: Item 3.02 unregistered equity sale; Item 5.02 officer or director change
- 2026-10-06 Filing 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2026-10-05 Filing PRE 14A filed
- 2026-09-03 Filing 8-K filed: Item 3.01 delisting notice
- 2026-08-13 Filing 10-Q filed
- 2026-08-06 Filing 8-K filed: Item 4.01 auditor change; Item 9.01 exhibits
- 2026-07-17 Filing EFFECT filed
- 2026-07-15 Filing EFFECT filed
- 2026-07-13 Filing S-1 filed
- 2026-07-13 Filing POS AM filed
- 2026-06-23 Filing 424B5 filed
- 2026-06-22 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 9.01 exhibits
- 2026-06-15 Filing 424B5 filed
- 2026-06-12 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 9.01 exhibits
- 2026-05-27 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 9.01 exhibits
- 2026-05-14 Filing 10-Q filed
- 2026-04-30 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-04-29 Filing EFFECT filed
- 2026-04-28 Filing CORRESP filed
- 2026-04-27 Filing UPLOAD filed
8-K item text, as filed (excerpts)
- 2026-10-19 8-K Item 3.02, Unregistered Sales of Equity Securities
On October 15, 2026, Nexentis Technologies Inc. (the “Company”) issued (i) 51,000 shares of common stock to a consultant for accounting and controller services provided to the Company; (ii) 101,549 shares of its common stock to David Palach, its Chief Executive Officer; (iii) 51,000 shares of common stock to Lital Barda, its Chief Financial Officer; (iv) an aggregate of 208,639 shares of common stock to the Company’s directors, in each case under its 2022 Share Incentive Plan (the “Plan”); and (v) an aggregate of 510,000 shares of common stock outside of the Plan to consultants in consideration of various financial, investor relations and business development services provided to the… the 8-K · retrieved 2026-11-19 15:58 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1789192.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001789192. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.